NCT00000993View on ClinicalTrials.gov

A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000993 - A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus | Biotech Hunter | Biotech Hunter